ONSET, DURATION, AND MANAGEMENT OF EDEMA AND EFFUSION IN PATIENTS TREATED WITH LONCASTUXIMAB TESIRINE FOR R/R DLBCL: UPDATED RESULTS FROM THE LOTIS-2 CLINICAL TRIAL

Grandas, C; Hendrickson, L; Alderuccio, JP; Hess, B; Ungar, D; Solh, M

ONCOLOGY NURSING FORUM, 2022; 49 (2): E56